Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer
Clinical trial NCT00083993 · TERMINATED
Trial details
- NCT number
- NCT00083993
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-10-01
- Enrollment
- 1236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.